International consensus statement for the use of botulinum toxintreatment in adults and children with neurological impairments – introduction: Esquenazi A et al.


European Journal of Neurology   2010, 17  (Suppl. 2): 1–8 
A. Esquenazi a,
I. Novak b,
G. Sheean c,
B. J. Singer d
and A. B. Ward e


Author Details:
a  Moss Rehab Gait & Motion Analysis Laboratory, Department of PM&R, Elkins Park, PA, USA;
b  Cerebral Palsy Institute, School of Medicine, University of Notre Dame Australia, Darlinghurst, Sydney, New South Wales, Australia;
c  Neurosciences, University of California, San Diego, California, USA;
d  Centre for Musculoskeletal Studies, School of Surgery, The University of Western Australia, Perth, Australia;
and e  North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire (Haywood Hospital), Stoke on Trent, UK